YEAR-END AND Q4 EARNINGS REPORTS FROM MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANIES pointed to a welcome sign of core diagnostic business rebounding. That’s the good news for IVD firms. The bad news? All of the SARS-CoV-2 testing revenue that these companies brought in over the last three years—as clinical laboratories and the general public demanded […]
Public IVD Companies Report Q4, Full-Year 2022 Earnings
In 2022/Q4, IVD companies see base business rise even as COVID-19 test revenue continues to drop
- By Robert Michel
- > From the Volume XXX No. 3 - February 13, 2023 Issue
- Tags: Abbott Laboratories, Beckman Coulter, bioMerieux, Cepheid, Cobas Infinity Laboratory Solution, covid-19 testing, Danaher, digital pathology, earnings report, FDA, Fierce Biotech, glioma neuropathology immunohistochemistry, IHC, in vitro diagnostics, IVD, ivd/lab informatics, Leica, Leica Microsystems, LightCycler Pro, Marc Casper, Matt Sause, Rainer Blair, Respiratory syncytial virus, Robert Ford, roche diagnostics, RSV, SARS-CoV-2, Serin Schwan, Thermo Fisher Scientific, U.S. Food and Drug Administration
